Cheng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cheng Chen has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
Haitao Yang
School of Life Sciences, Tianjin University, Tianjin 300072, China; Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China
5 shared publicationsFenghua Wang
School of Life Sciences, Tianjin University, Tianjin 300072, People's Republic of China
4 shared publications- Haitao Yang
ShanghaiTech University
4 shared publications Jinshan Wang
School of Life Sciences, Tianjin University, Tianjin 300072, People's Republic of China
4 shared publicationsQi Zhao
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA
4 shared publicationsShuang Li
School of Life Sciences, Tianjin University, Tianjin 300072, China; Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China
4 shared publications
Latest Publications
- 15 October 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 254 (Pt 3) , 118537
Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma
- 15 October 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 254 (Pt 3) , 118537
Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma
- 11 June 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (25) , 15959-15966
Structural Basis for the Exceptional Thermal Stability of the Boiling-Resistant Sweet Protein MNEI
Monellin, known as the sweetest protein, encounters limitations in the food industry due to its poor thermal stability, prompting modifications to enhance its thermal stability. In our previous work, we utilized Python Rosetta to screen multiple designs, successfully constructing four superstable MNEI (single-chain monellin) mutants that can maintain their sweetness at temperatures up to 100 °C. However, the precise mechanism of increased thermal stability remains unclear. To elucidate the mechanism, we determine the high-resolution crystal structures of four superstable mutants and conduct a comprehensive structural analysis combined with molecular dynamics simulations in our study. Our findings indicate that introduction of mutation sites enhances interactions with surrounding residues in some flexible loop regions, particularly in loop K25-R31, potentially stabilizing flexible regions and may contribute to enhancing the rigidity of the global structure. This study provides a direction for further advancement in mutant modifications.
- 11 June 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (25) , 15959-15966
Structural Basis for the Exceptional Thermal Stability of the Boiling-Resistant Sweet Protein MNEI
Monellin, known as the sweetest protein, encounters limitations in the food industry due to its poor thermal stability, prompting modifications to enhance its thermal stability. In our previous work, we utilized Python Rosetta to screen multiple designs, successfully constructing four superstable MNEI (single-chain monellin) mutants that can maintain their sweetness at temperatures up to 100 °C. However, the precise mechanism of increased thermal stability remains unclear. To elucidate the mechanism, we determine the high-resolution crystal structures of four superstable mutants and conduct a comprehensive structural analysis combined with molecular dynamics simulations in our study. Our findings indicate that introduction of mutation sites enhances interactions with surrounding residues in some flexible loop regions, particularly in loop K25-R31, potentially stabilizing flexible regions and may contribute to enhancing the rigidity of the global structure. This study provides a direction for further advancement in mutant modifications.
- Open Access
- 29 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (11) , e2413185
Structural Insights into the Substrate Recognition of Ginsenoside Glycosyltransferase Pq3‐O‐UGT2
Ginsenosides are a group of tetracyclic triterpenoids with promising health benefits, consisting of ginseng aglycone attached to various glycans. Pq3‐O‐UGT2, an important UDP‐dependent glycosyltransferase (UGT), catalyzes the production of Ginsenoside Rg3 and Rd by extending the glycan chain of Ginsenoside Rh2 and F2, respectively, with higher selectivity for F2. However, the mechanism underlying its substrate recognition remains unclear. In this study, the crystal structures of Pq3‐O‐UGT2 in complex with its acceptor substrates are solved. The structures revealed a Nα5‐oriented acceptor binding pocket in Pq3‐O‐UGT2, shaped by the unique conformation of the Nα5‐Nα6 linker. Hydrophobic interactions play a pivotal role in the recognition of both Rh2 and F2, while hydrogen bonds specifically aid in F2 recognition due to its additional glucose moiety. The hydrophobic nature of the acceptor binding pocket also enables Pq3‐O‐UGT2 to recognize flavonoids. Overall, this study provides novel insights into the substrate recognition mechanisms of ginsenoside UGTs, advancing the understanding of their function and specificity.
- 29 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (11) , e2413185
Open AccessStructural Insights into the Substrate Recognition of Ginsenoside Glycosyltransferase Pq3‐O‐UGT2
Ginsenosides are a group of tetracyclic triterpenoids with promising health benefits, consisting of ginseng aglycone attached to various glycans. Pq3‐O‐UGT2, an important UDP‐dependent glycosyltransferase (UGT), catalyzes the production of Ginsenoside Rg3 and Rd by extending the glycan chain of Ginsenoside Rh2 and F2, respectively, with higher selectivity for F2. However, the mechanism underlying its substrate recognition remains unclear. In this study, the crystal structures of Pq3‐O‐UGT2 in complex with its acceptor substrates are solved. The structures revealed a Nα5‐oriented acceptor binding pocket in Pq3‐O‐UGT2, shaped by the unique conformation of the Nα5‐Nα6 linker. Hydrophobic interactions play a pivotal role in the recognition of both Rh2 and F2, while hydrogen bonds specifically aid in F2 recognition due to its additional glucose moiety. The hydrophobic nature of the acceptor binding pocket also enables Pq3‐O‐UGT2 to recognize flavonoids. Overall, this study provides novel insights into the substrate recognition mechanisms of ginsenoside UGTs, advancing the understanding of their function and specificity.
- Open Access
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1418061
The potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis
Extracellular vesicles (EVs), characterized by low immunogenicity, high biocompatibility and targeting specificity along with excellent blood-brain barrier permeability, are increasingly recognized as promising drug delivery vehicles for treating a variety of diseases, such as cancer, inflammation and viral infection. However, recent findings demonstrate that the intracellular delivery efficiency of EVs fall short of expectations due to phagocytic clearance mediated by the host mononuclear phagocyte system through Fcγ receptors, complement receptors as well as non-opsonic phagocytic receptors. In this text, we investigate a range of bacterial virulence proteins that antagonize host phagocytic machinery, aiming to explore their potential in engineering EVs to counteract phagocytosis. Special emphasis is placed on IdeS secreted by Group A Streptococcus and ImpA secreted by Pseudomonas aeruginosa, as they not only counteract phagocytosis but also bind to highly upregulated surface biomarkers αVβ3 on cancer cells or cleave the tumor growth and metastasis-promoting factor CD44, respectively. This suggests that bacterial anti-phagocytic proteins, after decorated onto EVs using pre-loading or post-loading strategies, can not only improve EV-based drug delivery efficiency by evading host phagocytosis and thus achieve better therapeutic outcomes but also further enable an innovative synergistic EV-based cancer therapy approach by integrating both phagocytosis antagonism and cancer targeting or deactivation.
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1418061
Open AccessThe potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis
Extracellular vesicles (EVs), characterized by low immunogenicity, high biocompatibility and targeting specificity along with excellent blood-brain barrier permeability, are increasingly recognized as promising drug delivery vehicles for treating a variety of diseases, such as cancer, inflammation and viral infection. However, recent findings demonstrate that the intracellular delivery efficiency of EVs fall short of expectations due to phagocytic clearance mediated by the host mononuclear phagocyte system through Fcγ receptors, complement receptors as well as non-opsonic phagocytic receptors. In this text, we investigate a range of bacterial virulence proteins that antagonize host phagocytic machinery, aiming to explore their potential in engineering EVs to counteract phagocytosis. Special emphasis is placed on IdeS secreted by Group A Streptococcus and ImpA secreted by Pseudomonas aeruginosa, as they not only counteract phagocytosis but also bind to highly upregulated surface biomarkers αVβ3 on cancer cells or cleave the tumor growth and metastasis-promoting factor CD44, respectively. This suggests that bacterial anti-phagocytic proteins, after decorated onto EVs using pre-loading or post-loading strategies, can not only improve EV-based drug delivery efficiency by evading host phagocytosis and thus achieve better therapeutic outcomes but also further enable an innovative synergistic EV-based cancer therapy approach by integrating both phagocytosis antagonism and cancer targeting or deactivation.
- 4 January 2024
- Published by Elsevier in Protein Expression and Purification
- Vol. 216, 106430
Expression, purification, characterization and crystallization of Panax quinquefolius ginsenoside glycosyltransferase Pq3-O-UGT2
- 4 January 2024
- Published by Elsevier in Protein Expression and Purification
- Vol. 216, 106430
Expression, purification, characterization and crystallization of Panax quinquefolius ginsenoside glycosyltransferase Pq3-O-UGT2
- Open Access
The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals
The existing zoonotic coronaviruses (CoVs) and viral genetic variants are important microbiological pathogens that cause severe disease in humans and animals. Currently, no effective broad-spectrum antiviral drugs against existing and emerging CoVs are available. The CoV main protease (Mpro) plays an essential role in viral replication, making it an ideal target for drug development. However, the structure of the Deltacoronavirus Mpro is still unavailable. Porcine deltacoronavirus (PDCoV) is a novel CoV that belongs to the genus Deltacoronavirus and causes atrophic enteritis, severe diarrhea, vomiting and dehydration in pigs. Here, we determined the structure of PDCoV Mpro complexed with a Michael acceptor inhibitor. Structural comparison showed that the backbone of PDCoV Mpro is similar to those of alpha-, beta- and gamma-CoV Mpros. The substrate-binding pocket of Mpro is well conserved in the subfamily Coronavirinae. In addition, we also observed that Mpros from the same genus adopted a similar conformation. Furthermore, the structure of PDCoV Mpro in complex with a Michael acceptor inhibitor revealed the mechanism of its inhibition of PDCoV Mpro. Our results provide a basis for the development of broad-spectrum antivirals against PDCoV and other CoVs.
Open AccessThe Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals
The existing zoonotic coronaviruses (CoVs) and viral genetic variants are important microbiological pathogens that cause severe disease in humans and animals. Currently, no effective broad-spectrum antiviral drugs against existing and emerging CoVs are available. The CoV main protease (Mpro) plays an essential role in viral replication, making it an ideal target for drug development. However, the structure of the Deltacoronavirus Mpro is still unavailable. Porcine deltacoronavirus (PDCoV) is a novel CoV that belongs to the genus Deltacoronavirus and causes atrophic enteritis, severe diarrhea, vomiting and dehydration in pigs. Here, we determined the structure of PDCoV Mpro complexed with a Michael acceptor inhibitor. Structural comparison showed that the backbone of PDCoV Mpro is similar to those of alpha-, beta- and gamma-CoV Mpros. The substrate-binding pocket of Mpro is well conserved in the subfamily Coronavirinae. In addition, we also observed that Mpros from the same genus adopted a similar conformation. Furthermore, the structure of PDCoV Mpro in complex with a Michael acceptor inhibitor revealed the mechanism of its inhibition of PDCoV Mpro. Our results provide a basis for the development of broad-spectrum antivirals against PDCoV and other CoVs.
- 1 July 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 528 (3) , 601-606
Crystal structure of the NS3 helicase of tick-borne encephalitis virus
- 1 July 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 528 (3) , 601-606
Crystal structure of the NS3 helicase of tick-borne encephalitis virus
- Open Access
- 25 May 2020
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 11 (8) , 606-612
Structure of African swine fever virus p15 reveals its dual role for membrane-association and DNA binding
- 25 May 2020
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 11 (8) , 606-612
Open AccessStructure of African swine fever virus p15 reveals its dual role for membrane-association and DNA binding